The aim of this research was to develop and evaluate gastric floating tablets of salbutamol sulphate.
INTRODUCTION
Gastric emptying of pharmaceutical dosage form is an extremely variable process and ability to prolong and control the emptying time is a valuable asset for dosage forms, which reside in the stomach for a longer period of time than conventional dosage forms. Several difficulties are faced in designing controlled release systems for better absorption and enhanced bioavailability. 1 The floating drug delivery systems can retain drugs in the stomach for prolonged time to improve the oral bioavailability of the drugs that have site-specific absorption from the stomach or upper part of the small intestine. These systems help in continuously releasing the drug in the stomach, thus ensuring optimal bioavailability. 2 Therefore, different approaches have been proposed to retain the dosage form in the stomach including bioadhesive system 3 , swelling and expanding system 4 , floating system 5 and delayed gastric emptying devices. 6 The principle of buoyant preparation offers a simple and practical approach to achieve increased gastric residence time for the dosage form and sustained drug release.
Salbutamol sulphate is a sympathomimetic amine which is used as a bronchodilator in the treatment of reversible bronchospasm. It is almost exclusively metabolized by conjugation to a 4'-Osulphate ester in the intestinal wall and liver. Salbutamol sulphate is freely soluble in water and has site-specific absorption in stomach and upper part of small intestine. 7 The maximum plasma concentration occurs within 2.5 h and plasma half life ranges from 2. The aim of the present study was to formulate and characterize oral floating tablets of salbutamol sulphate using different polymers like carbopol, xantnan gum, HPMC-K4 MCR and HPMC-K100 MCR which acted as both buoyancy agents as well as a release-retarding polymer. Citric acid and sodium hydrogen carbonate were incorporated as gas generating agents. In order to develop the floating matrix tablet of salbutamol sulphate, it is necessary to optimize both the residence time of the system in the gastro intestinal tract and release rate of the drug from the dosage. The impact of polymer content and types upon release rate were investigated.
MATERIALS AND METHODS
Materials and reagents. Salbutamol sulphate was a gift sample from Amico Laboratories Ltd, Bangladesh. Carbopol, xantnan gum, HPMC-K4 MCR and HPMC-K100 MCR were obtained from ACI Ltd, Bangladesh. Sodium bicarbonate (Merck, Gernamny), citric acid (Loba, India), lactose and povidone K-30 were purchased from local market. The source of magnesium stearate and talc were Willfrid Smith Ltd, UK. Sodium hydroxide and potassium dihydrogen phosphate were procured from Merck, Germany. Distilled water was collected from the own research laboratory. Weight of each ingredient was taken in mg.
Preparation of oral floating tablets of salbutamol sulphate. Salbutamol sulphate floating tablets were prepared by direct compression using different polymers like carbopol, xanthan gum, HPMC K4M and HPMC K100M as matrix former and sodium bicarbonate and citric acid as floating agents. Amount of various ingredients used in different formulations of floating tablets are presented in table 1. Appropriate amounts of the mixture were accurately weighed with an electronic balance for the preparation of each tablet and finally the amounts were compressed using a Perkin-Elmer laboratory hydraulic press. Before compression, the surfaces of the die and punch were lubricated with magnesium stearate. All the preparations were stored in airtight containers at room temperature for further studies.
Physical tests. The compressed tablets were characterized by their physical properties. The average tablet weight was determined from 20 tablets.
10 20 tablets of each of the formulations were measured diametrically. The values were displayed in millimeters (mm). Similarly, 20 tablets of each of the formulations were taken and thicknesses were measured in the same machine and the values were displayed in millimeters (mm). Hardness of the tablets was tested using a Monsanto tablet hardness tester. Friability of the tablets was determined in Roche friabilator. Tablet friability was calculated as the percentages of weight loss of 20 tablets after 100 rotations.
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The physical parameters for the compressed tablets were provided in table 2.
In vitro buoyancy study. According to the reliable reference of Rosa et al., (1994) 11 the in vitro buoyancy was determined by floating lag time. The tablets were placed in a 100-mL beaker containing 0.1N HCl. The time required for the tablet to rise to the surface and float was determined as floating lag time shown in table 2.
Dissolution studies. Dissolution tests of salbutamol sulphate oral floating tablets were conducted according to the USP method (USP XXII) using apparatus 2. In all cases the conditions were maintained to be exactly the same, i.e. the rpm was maintained at 50 while the temperature maintained always at 37 ± 0.5 °C and phosphate buffer of pH 6.8 was used as dissolution media. The dissolution was carried out for 12 hrs. This was done to get a simulated picture of drug release in the in-vivo condition. The collected sample was first filtered, and then diluted before being assayed at 276 nm using UV spectrophotometer. The percentage of drug released was calculated and plotted against time.
RESULTS AND DISCUSSION
Physical parameters of oral floating tablets of salbutamol sulphate. The average weight of the tablets was found uniform and standardized at approximately 390 mg. The average diameter was found to be much consistent of 13.08 mm and the average thickness ranged from 2.09-2.19 mm. On the contrary, the friability of the tablets of different formulations varied greatly ranging from 0.125-0.218%. According to some authentic references the maximum friability range should be 0.5-1%. Buoyancy and total floating test. From the results, it was observed that the buoyancy lag time and the total floating time was studied for all the formulations as shown in table 3. Results revealed that as the concentration of the ratio of polymer increases, the buoyancy lagging time decreases and constantly floated on dissolution medium. Floating lag times were found to be significantly controlled by sodium bicarbonate and citric acid content. It was reduced due to increase of amount of floating agent which caused rapid formation and entrapment of CO 2 gas into the polymeric gel. The optimized formulation F-11 gives the best result in terms of the required lag time (1-2 minutes) and floating duration of >12 hrs.
Zero order model analysis.
A drug is said to be released by zero order kinetics when the rate of release of drug is independent of the concentration of drug in the tablet. Percent release profile includes a plot of percent release of drug versus time. The dissolution data by zero order model revealed that maximum drug was released after 12 hours by the F-1 (99.12%), while F-11 released only (87.34%) of drug at the same time and thus showing a more sustaining action than other formulations. Figure 1 shows the zero order release of salbutamol sulphate from all the formulations of the present study. At low concentration of polymer, the release of drug was generally seen more and at the high concentration of polymer, the release of drug was generally seen to decrease. This was applicable for all the polymers of the present study. Interpretation of effervescent salbutamol sulphate tablets. In F-12, polymer was absent while gas generating agents (sodium bicarbonate and citric acid) were present. The release profile showed (Figure 2 ) that F-12 released 100% drug within 2 hours. So without polymer the formulated tablets showed normal effervescent tablets. Hence, we concluded that the effervescent tablets of salbutamol sulphate formulated by gas generating agents, sodium bicarbonate and citric acid without polymer could not control the drug release upto 12 hours. The incorporation of different ratios of different polymers shows well-controlled gastric floating tablets of salbutamol sulphate.
CONCLUSION
Floating drug delivery system has great promise to be a potential approach for gastric retention. Development of floating drug delivery system is beneficial for optimal therapy regarding efficacy, safety and patient compliance. F-11 exhibited higher retarding and better buoyancy properties more effectively than all other formulations. On the contrary, F-12 formulated by gas generating agents in which polymer was absent displayed the normal effervescent tablets of salbutamol sulphate. The result of this study revealed that same methodology can be used to formulate floating tablets for different drugs with optimum absorption to decrease dosage frequency.
